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1 |  INTRODUCTION
A 53-year-old man was admitted to the hospital and was 
treated for COVID-19. Twenty-two days after discharge, 
the patient made an appointment complaining of persistent 
cough and hemoptysis. Follow-up chest X-ray showed an air-
fluid level in the right lung. The chest CT scan showed a lung 
abscess
In late 2019, a new respiratory infection was spreading 
all around the world.1 Novel coronavirus disease (COVID-
19) became a pandemic according to the World Health 
Organization on 11 March 2020. The first COVID-19 patient 
in Iran was diagnosed on 19 February 2020, at Qom city. In 
Hazrat-e-Rasoul general hospital, the first administered pa-
tient was diagnosed on 20 February 2020, after a short trip to 
Qom (Figures 1-4).
The disease's main clinical characteristics are myalgia, 
fever, cough, respiratory distress, and shortness of breath.2,3
The diagnosis of COVID-19 is based on the clinical 
manifestations, laboratory testing, and imaging. Reverse 
transcription polymerase chain reaction (RT-PCR) test from 
nasopharyngeal swab samples and typical chest computerized 
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To our knowledge, no previous studies have reported lung abscess as a complication 
of COVID-19 infection. It is essential to follow-up with the patients after discharge 
for such complications, especially if they are symptomatic.
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tomography (CT) characteristics confirms the diagnosis of 
COVID-19.4 Chest CT scan had a sensitivity of 97% for diag-
nosing COVID-19 based on physicians’ experience, which is 
even superior to RT-PCR.5
Every day, a new manifestation of COVID-19 is re-
vealed. Late complications of COVID-19 infection are not 
fully understood. The treatments and other interventions 
used for COVID-19 are mostly experimental, and the effec-
tiveness and complications of such treatments are still un-
known. As medical workers, we must inform our coworkers 
and share our experiences. In this article, we are presenting 
a COVID-19-positive patient with remarkable complication 
after receiving treatment.
2 |  CASE PRESENTATION
A 53-year-old previously healthy man admitted to the iso-
lated respiratory ward due to fever, myalgia, cough, and 
shortness of breath. On the initial examination, he had a 
low-grade fever with a temperature of 37.8 centigrade and 
tachypnea with a respiratory rate of 23 per minute. Oxygen 
saturation was 90 percent on room air. His lungs examination 
revealed mild crackles in both basal lungs fields. Chest CT 
scan showed ground glass, patchy pleural-based consolida-
tions of lung parenchyma.
The patient was treated with Hydroxychloroquine 200mg 
every 12 hours, accompanied by other supportive cares such 
as hydration and oxygen therapy.
Four days after admission, the symptom began to re-
cuperate, and the patient was discharged to receive the 
rest of the treatment course at home. The patient receives 
Hydroxychloroquine for 14 days. It was recommended that 
the patient visit the day clinic for a better follow-up of the 
healing process.
The patient made an appointment to our day clinic 22 days 
after discharge, complaining of persistent cough and hemoptysis. 
Therefore, a follow-up chest X-ray was taken. To our surprise, an 
air-fluid level was seen in the lower lobe of the right lung.
F I G U R E  1  Chest X-ray at first admission
F I G U R E  2  Chest CT scan at first 
admission
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For a better understanding of the etiology of this imaging 
finding, a lung chest CT scan was ordered, and the patient 
was admitted to an isolated respiratory ward for further eval-
uation and treatment. The lung CT scan showed an abscess 
with fluid in the right lower lobe. The patient was treated 
with intravenous Ampicillin–Sulbactam three gram every 
eight hours and oral Azithromycin 250mg every 12 hours. 
The laboratory data are available in Table 1.
The nasopharyngeal swap was negative, but the serol-
ogy of the COVID-19 antibody for both IgM and IgG was 
positive. After 11 days of intravenous antibacterial ther-
apy, the hemoptysis was resolved. At the follow-up chest 
CT scan, the abscess was improving and showed signs of 
remission.
At discharge, oral Amoxicillin–Clavulanic acid 625mg 
every eight hours, supplemented with oral Ciprofloxacin 
500mg every 12 hours, was prescribed for a week.
3 |  DISCUSSION
Even though COVID-19 is a respiratory virus, research 
showed that this viral infection could involve many other or-
gans in the body. Cardiovascular involvement, heart failure, 
renal failure, liver damage, shock, and multi-organ failure are 
other manifestations' of COVID-19.6 Studies even showed 
neurological complications of COVID-19.7 The coronavirus 
can cause some hematologic complications such as lympho-
cytopenia, thrombocytopenia, coagulopathies, and dissemi-
nated intravenous coagulation.8
Lung abscess is usually a cavity formation as a result of 
lung tissue necrosis. Bacterial infection and aspiration can 
lead to abscess formation.
Lung tissue diseases cause primary abscesses. On the 
other hand, secondary abscesses are usually due to other 
medical conditions such as pulmonary thromboembolism or 
the spread of extrapulmonary abscesses to the lungs.
F I G U R E  3  Chest X-ray at second admission
F I G U R E  4  Chest CT scan with lung 
abscess
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In this patient, the pulmonary symptoms and lung abscess 
started after discharge. The patient had no history of alco-
hol consumption or substance abuse. He showed no signs 
of esophageal dysfunction. He had not experienced any loss 
of consciousness or seizures. His oral hygiene was optimal. 
After precise history taking and laboratory data evaluations, 
immunodeficiency diseases were excluded. The only recent 
illness was COVID-19 infection.
The patient was tested for tuberculosis, considering 
that tuberculosis is endemic in Iran. The results came back 
negative. Because of recent COVID-19 infection and pos-
itive serology and clinical improvement of lung abscess 
after the administration of antibiotics, the treatment team 
decided that the bronchoscopy is not necessary for the 
patient.
To our knowledge, no previous studies have reported 
lung abscess as a complication of COVID-19 infection. 
It is important to follow-up with the patients after dis-
charge for such complications, especially if the patients are 
symptomatic.
4 |  CONCLUSION
COVID-19 is a novel virus, and a lot is remained to under-
stand the pathophysiology of this disease. In this case report, 
we presented a previously healthy patient who developed a 
lung abscess after receiving treatment for COVID-19. The 
practitioners should be aware of such complications and look 
for it.
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Test Unit First admission
Second 
admission Discharge
WBC *1000/mm3 6 6.1 7.3
segment Percent 72 55.8 43.3
lymphocyte Percent 19 39.2 42.1
Hb g/dl 14.3 13.5 13.7
MCV Fl 80.5 81.7 82.4
Plt *1000/mm3 214 278 275
Creatinine mg/dl 1.2 1 1.2
BUN mg/dl 16 14 13
Na mEq/dl 136 137
K mEq/dl 4.2 5.4
P mg/dl 3.5 3.8
Ca mg/dl 8.5 9.1
Alb g/dl 3.8
Mg mg/dl 1.9 2.7
AST IU/L 49 30
ALT IU/L 44 36
Alk.p IU/L 93 176
Bili Total mg/dl 0.4
Bili Direct mg/dl 0.2
CPK IU/L
LDH U/L 457 366
ESR mm/hr 45 31 16
CRP mg/l 6 6
PT Sec 13 13
INR Indx 1 1
PTT Sec 39 29
T A B L E  1  Laboratory data
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